UBS Reiterates Buy Rating on Vertex (VRTX) after positive doc call on Journavx uptake
Tweet Send to a Friend
UBS analyst Eliana Merle reiterated a Buy rating and $582.00 price target on Vertex (NASDAQ: VRTX) after talking a bullish ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
